Ghent University
暂无分享,去创建一个
R. Vanholder | N. Stroobant | G. Glorieux | N. Neirynck | Nathalie Stroobant | G. Van Nooten | Woord vooraf | G. Nooten | Woord vooraf | Uremic Peptides | T. D. Backer
[1] Jarl Risberg,et al. Observations on the functional significance of regional cerebral blood flow in “resting” normal subjects , 1980, Neuropsychologia.
[2] R. Aaslid,et al. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. , 1982, Journal of neurosurgery.
[3] T. Treasure,et al. CEREBRAL CONSEQUENCES OF CARDIOPULMONARY BYPASS , 1986, The Lancet.
[4] J. French,et al. Early intellectual dysfunction following coronary bypass surgery. , 1986, The Quarterly journal of medicine.
[5] J. French,et al. Long-term intellectual dysfunction following coronary artery bypass graft surgery: a six month follow-up study. , 1987, The Quarterly journal of medicine.
[6] J. Blass,et al. Unrecognized Cognitive Impairment in Cardiac Rehabilitation Patients , 1988, Journal of the American Geriatrics Society.
[7] A. Harders,et al. A transcranial Doppler study of blood flow velocity in the middle cerebral arteries performed at rest and during mental activities. , 1989, Stroke.
[8] N. Ochner. World Literature Today: A Literary Quarterly of the University of Oklahoma , 1989 .
[9] E B Ringelstein,et al. Transcranial Doppler sonography: anatomical landmarks and normal velocity values. , 1990, Ultrasound in medicine & biology.
[10] T. Benke,et al. Neuropsychological deficits in asymptomatic carotid artery stenosis , 1991, Acta neurologica Scandinavica.
[11] J. van der Linden,et al. When do cerebral emboli appear during open heart operations? A transcranial Doppler study. , 1991, The Annals of thoracic surgery.
[12] B. G. Rule,et al. The Impact of Pacemaker Implantation on Cognitive Functioning in Elderly Patients , 1992, Journal of the American Geriatrics Society.
[13] J. Murkin. Neurologic dysfunction after CAB or valvular surgery: is the medium the miscreant? , 1993, Anesthesia and analgesia.
[14] S. Nakamura,et al. Selective removal of beta 2-microglobulin from plasma specimens of long-term hemodialysis patients by high-performance immunoaffinity chromatography. , 1993, Clinical chemistry.
[15] C Caltagirone,et al. Bilateral Simultaneous Assessment of Cerebral Flow Velocity during Mental Activity , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] E. Ringelstein,et al. Transcranial Doppler ultrasonic assessment of middle cerebral artery blood flow velocity changes during verbal and visuospatial cognitive tasks , 1994, Neuropsychologia.
[17] J. J. Claus,et al. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study , 1994, BMJ.
[18] H. Seo,et al. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. , 1994, The Journal of clinical investigation.
[19] C. Naylor,et al. Cardiopulmonary bypass, temperature, and central nervous system dysfunction. , 1994, Circulation.
[20] C. Dougherty,et al. Longitudinal recovery following sudden cardiac arrest and internal cardioverter defibrillator implantation: survivors and their families. , 1994, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[21] T. Treasure,et al. The Impact of Microemboli During Cardiopulmonary Bypass on Neuropsychological Functioning , 1994, Stroke.
[22] C. Blauth,et al. Macroemboli and microemboli during cardiopulmonary bypass. , 1995, The Annals of thoracic surgery.
[23] W. White,et al. Predictors of cognitive decline after cardiac operation. , 1995, The Annals of thoracic surgery.
[24] M. Harrison,et al. Neurologic complications of coronary artery bypass grafting: diffuse or focal ischemia? , 1995, The Annals of thoracic surgery.
[25] Y. Juliano,et al. Neurological outcome in coronary artery surgery with and without cardiomlmonarv bypass , 1995, Acta neurologica Scandinavica.
[26] C. Mazer,et al. Cerebral microemboli during coronary artery bypass using different cardioplegia techniques. , 1995, The Annals of thoracic surgery.
[27] R. E. Clark,et al. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. , 1995, The Journal of thoracic and cardiovascular surgery.
[28] M. Kaps,et al. Is there a hemispheric side preference of cardiac valvular emboli? , 1995, Ultrasound in medicine & biology.
[29] W D White,et al. Defining neuropsychological dysfunction after coronary artery bypass grafting. , 1996, The Annals of thoracic surgery.
[30] J. Gold,et al. Comparison of transcranial Doppler ultrasonography and transesophageal echocardiography to monitor emboli during coronary artery bypass surgery. , 1996, Stroke.
[31] K. Fox,et al. Chronic memory impairment after cardiac arrest outside hospital , 1996, BMJ.
[32] W. Skreczek,et al. Hemispheric asymmetry of arterial blood flow velocity changes during verbal and visuospatial tasks , 1996, Neuropsychologia.
[33] J. Hammon,et al. Cerebral emboli and cognitive outcome after cardiac surgery. , 1996, Journal of cardiothoracic and vascular anesthesia.
[34] G. Vingerhoets,et al. Prospective evaluation of verbal memory performance after cardiopulmonary bypass surgery. , 1996, Journal of clinical and experimental neuropsychology.
[35] J. Gold,et al. Impact of embolization during coronary artery bypass grafting on outcome and length of stay. , 1997, The Annals of thoracic surgery.
[36] J. Svennevig,et al. Cerebral microembolic signals during cardiopulmonary bypass surgery. Frequency, time of occurrence, and association with patient and surgical characteristics. , 1997, Stroke.
[37] G. Vingerhoets,et al. Neuropsychological impairment in candidates for cardiac surgery , 1997, Journal of the International Neuropsychological Society.
[38] A. Cope,et al. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. , 1998, The Journal of clinical investigation.
[39] S. Newman,et al. Cerebral functional changes following cardiac surgery: Neuropsychological and EEG assessment. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[40] P. Halligan,et al. Is cardiopulmonary bypass still the cause of cognitive dysfunction after cardiac operations? , 1999, The Journal of thoracic and cardiovascular surgery.
[41] W. Boyd,et al. Beating heart surgery: why expect less central nervous system morbidity? , 1999, The Annals of thoracic surgery.
[42] GuyVingerhoets,et al. Lateralization of Cerebral Blood Flow Velocity Changes During Cognitive Tasks , 1999 .
[43] M. Borger,et al. Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. , 1999, The Annals of thoracic surgery.
[44] S. Wan,et al. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. , 1999, The Annals of thoracic surgery.
[45] R. Petersen,et al. Cost-effectiveness of minimally invasive coronary artery bypass surgery. , 1999, The Annals of thoracic surgery.
[46] T. Ikizler,et al. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis. , 2000, Kidney international.
[47] G. Angelini,et al. Reduced cerebral embolic signals in beating heart coronary surgery detected by transcranial Doppler ultrasound. , 2000, British journal of anaesthesia.
[48] V Falk,et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. , 2000, The Annals of thoracic surgery.
[49] J. Hammon,et al. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. , 2000, Stroke.
[50] K V Arom,et al. Safety and efficacy of off-pump coronary artery bypass grafting. , 2000, The Annals of thoracic surgery.
[51] M. Galiñanes,et al. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. , 2000, The Annals of thoracic surgery.
[52] B. Soller,et al. Off-pump versus on-pump coronary artery bypass surgery: a case-matched comparison of clinical outcomes and costs. , 2000, The heart surgery forum.
[53] Bénédicte Ledent. A Fictional and Cultural Labyrinth: Caryl Phillip's "The Nature of Blood" , 2001 .
[54] C. Peniston,et al. Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. , 2001, The Journal of thoracic and cardiovascular surgery.
[55] C. Consani,et al. Reappraisal of serum beta2-microglobulin as marker of GFR. , 2001, Renal failure.
[56] D. Stump,et al. Does off-pump coronary artery bypass surgery reduce the risk of brain injury? , 2001, The heart surgery forum.
[57] M. Czerny,et al. Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting. , 2001, The Annals of thoracic surgery.
[58] J. D. Lee,et al. Coronary artery bypass performed without the use of cardiopulmonary bypass is associated with reduced cerebral microemboli and improved clinical results. , 2001, Chest.
[59] W. Owen,et al. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. , 2001, Kidney international.
[60] Lars Eckstein. The Insistence of Voices: An Interview with Caryl Phillips , 2001 .
[61] D Moshman,et al. Conceptual constraints on thinking about genocide , 2001, Journal of genocide research.
[62] S. Moe,et al. beta(2)-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts. , 2001, Kidney international.
[63] G. Vingerhoets,et al. Short-term and long-term neurocognitive outcome in on-pump versus off-pump CABG. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[64] N. Chen,et al. Signal transduction of beta2m-induced expression of VCAM-1 and COX-2 in synovial fibroblasts. , 2002, Kidney international.
[65] A. Moses. Conceptual blockages and definitional dilemmas in the 'racial century': genocides of indigenous peoples and the Holocaust , 2002 .
[66] L. Rasmussen,et al. Cerebral blood flow and cognitive dysfunction after coronary surgery. , 2002, The Annals of thoracic surgery.
[67] R. Brucher,et al. Online Automatic Discrimination Between Solid and Gaseous Cerebral Microemboli With the First Multifrequency Transcranial Doppler , 2002, Stroke.
[68] P. Smethurst. Postmodern Blackness and Unbelonging in the Works of Caryl Phillips , 2002 .
[69] J. Cavaillon,et al. Structural and functional analyses of bacterial lipopolysaccharides. , 2002, Microbes and infection.
[70] Raymond Vanholder,et al. Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.
[71] Ping-yan Chen,et al. Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. , 2004, Journal of the American Society of Nephrology : JASN.
[72] Guy Vingerhoets,et al. Transcranial Doppler Ultrasonography Monitoring of Cerebral Hemodynamics During Performance of Cognitive Tasks: A Review , 2000, Neuropsychology Review.
[73] Wendy Zierler. "My Holocaust Is Not Your Holocaust": "Facing" Black and Jewish Experience in The Pawnbroker, Higher Ground, and The Nature of Blood , 2004 .
[74] J. Manson,et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. , 2004, Journal of the American Society of Nephrology : JASN.
[75] P. D. De Deyn,et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. , 2004, Kidney international.
[76] A. Dawson. ‘To remember too much is indeed a form of madness’: Caryl Phillips's the nature of blood and the modalities of European racism , 2004 .
[77] L. Deecke,et al. Distribution of ischemic cerebrovascular events in cardiac embolism , 1991, Klinische Wochenschrift.
[78] Y. Saijo,et al. Relationship of β2-Microglobulin to Arterial Stiffness in Japanese Subjects , 2005, Hypertension Research.
[79] Z. Massy,et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[80] M. Haberal,et al. Cardiac troponin I and beta 2 microglobulin as risk factors for early‐onset atherosclerosis in patients on haemodialysis , 2005, Nephrology.
[81] Jürgen Zimmerer. The birth of the Ostland out of the spirit of colonialism: a postcolonial perspective on the Nazi policy of conquest and extermination , 2005 .
[82] A. Fokkema. Identity, trauma and exile: Caryl Phillips on surviving , 2005, European Review.
[83] T. Mayadas,et al. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. , 2005, The Journal of clinical investigation.
[84] R. Saunders,et al. Introduction: Mourning and Memory , 2005 .
[85] B. Palmer. History in Transit: Experience, Identity. Critical Theory , 2005 .
[86] William Clark,et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. , 2006, Journal of the American Society of Nephrology : JASN.
[87] J. Jankowski,et al. Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[88] R. Vanholder,et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[89] J. Griffith,et al. The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.
[90] E. Fung,et al. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. , 2007, Circulation.
[91] T. Mayadas,et al. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. , 2007, Seminars in nephrology.
[92] R. Vanholder,et al. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? , 2008, Journal of nephrology.
[93] S. Craps. Linking Legacies of Loss: Traumatic Histories and Cross-Cultural Empathy in Caryl Phillips’s Higher Ground and The Nature of Blood , 2008 .
[94] W. Dehaen,et al. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption. , 2007, Artificial organs.
[95] S. Sprague,et al. Beta2-microglobulin stimulates osteoclast formation. , 2008, Kidney international.
[96] M. Inaba,et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[97] R. Vanholder,et al. Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[98] N. Heegaard. beta(2)-microglobulin: from physiology to amyloidosis. , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[99] J. Manson,et al. Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling , 2010, Genome Medicine.
[100] K. Hirata,et al. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients. , 2010, Journal of cardiology.
[101] J. Jankowski,et al. Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[102] N. Tentolouris,et al. β2-Microglobulin, Pulse Pressure and Metabolic Alterations in Hemodialysis Patients , 2010, Nephron Clinical Practice.
[103] R. Vanholder,et al. New uremic toxins - which solutes should be removed? , 2011, Contributions to nephrology.
[104] C. Guo,et al. Plasma aluminum is a risk factor for oxidative stress and inflammation status in hemodialysis patients. , 2011, Clinical biochemistry.
[105] F. Locatelli,et al. What We Know About Oxidative Stress in Patients with Chronic Kidney Disease on Dialysis—Clinical Effects, Potential Treatment, and Prevention , 2011, Seminars in dialysis.
[106] Z. Massy,et al. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[107] J. Kals,et al. β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients , 2011, Scandinavian journal of clinical and laboratory investigation.
[108] O. Wagner,et al. Beta 2 Microglobulin and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis , 2011, Stroke.
[109] N. Levin,et al. Clearance of p-Cresol Sulfate and &bgr;-2-Microglobulin from Dialysate by Commercially Available Sorbent Technology , 2011, ASAIO journal.
[110] O. Wagner,et al. Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis , 2011, Thrombosis and Haemostasis.
[111] R. Vanholder,et al. Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[112] A. Cueto-Manzano,et al. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[113] T. Mayadas,et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.
[114] Raymond Vanholder,et al. Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.
[115] Z. Massy,et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. , 2012, Kidney international.
[116] B. Astor,et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[117] Z. Massy,et al. Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease , 2012, PloS one.
[118] T. Mayadas,et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.
[119] R. Sacco,et al. Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study. , 2013, Age and ageing.
[120] J. Murabito,et al. Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[121] M. Lindenmeyer,et al. Distinct Contributions of TNF Receptor 1 and 2 to TNF-Induced Glomerular Inflammation in Mice , 2013, PloS one.
[122] A. Martínez‐Castelao,et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. , 2013, Journal of the American Society of Nephrology : JASN.
[123] D. Stamatialis,et al. Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma. , 2013, Biomaterials.
[124] V. Rigalleau,et al. Association of Serum Concentration of TNFR1 With All-Cause Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease: Follow-up of the SURDIAGENE Cohort , 2014, Diabetes Care.
[125] H. Schiffl. Impact of advanced dialysis technology on the prevalence of dialysis‐related amyloidosis in long‐term maintenance dialysis patients , 2014, Hemodialysis international. International Symposium on Home Hemodialysis.